Results 11 to 20 of about 183 (60)

[Advances in clinical research on novel BTK inhibitors for the treatment of chronic lymphocytic leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2023
Qiu TL, Miao Y, Li JY.
europepmc   +1 more source

[Comparison of functional outcomes between tenecteplase and alteplase as bridging thrombolysis prior to mechanical throm-bectomy for acute ischemic stroke patients with large vessel occlusion]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Shi Z, Yang J, Lu Z, Cai Y, Zhu Y, Huang G, Zhu H, Lou M, Cheng J.   +8 more
europepmc   +1 more source

[Efficacy of intravenous thrombolysis beyond 4.5 to 24 hours in patients with isolated posterior circulation acute ischemic stroke]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Wang J, Yan S, Lang Y, Jin T, Tang H, Qian S, Yu H, Lou M, Chen H.   +8 more
europepmc   +1 more source

[Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2026)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Myeloma Committee-Chinese Hematology Association.   +3 more
europepmc   +1 more source

[Efficacy and safety of intravenous thrombolysis in patients with mild acute ischemic stroke]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Li X, Zhang X, Wang A, Wang T, Yan Y, Fu J, Zheng J, Lou M, Hu J.   +8 more
europepmc   +1 more source

[Research progress on toxic shock syndrome due to group A <i>Streptococcus</i> infection in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang HY, Zhou W, Huang LS.
europepmc   +1 more source

[Expert Consensus on Rational Use and Monitoring of Small Molecule Targeted Drugs for Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhao L, Tang K, Expert Consensus Working Group on Rational Use and Monitoring of Small Molecule Targeted Drugs for Lung Cancer, Lung Cancer Professional Committee of Guangdong Medical Women’s Association.   +3 more
europepmc   +1 more source

[Research advances in autoimmune liver disease in 2025: toward precision regulation and personalized treatment]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Shang YL, Han Y.
europepmc   +1 more source

[Expert consensus on the management of B-cell lymphoma-related cardiovascular diseases with Bruton tyrosine kinase inhibitors (2023)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2023
Hematological Oncology Committee of China Anti-Cancer Association, Chinese Society of Hematology, Chinese Medical Association, Chinese Workshop on Chronic Lymphocytic Leukemia.   +3 more
europepmc   +1 more source

[Chinese expert consensus on prevention and treatment of immunotherapeutic and molecular targeted agents-related infections in patients with hematological malignancies (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Infectiology Group, Chinese Society of Hematology, Chinese Medical Association, Lymphocytic Disease Group, Chinese Society of Hematology, Chinese Medical Association, Lymphoma Expert Committee of Chinese Society of Clinical Oncology.   +6 more
europepmc   +1 more source